Cargando…
Alzheimer's disease drug development pipeline: 2022
INTRODUCTION: Alzheimer's disease (AD) represents a global health crisis. Treatments are needed to prevent, delay the onset, slow the progression, improve cognition, and reduce behavioral disturbances of AD. We review the current clinical trials and drugs in development for the treatment of AD....
Autores principales: | Cummings, Jeffrey, Lee, Garam, Nahed, Pouyan, Kambar, Mina Esmail Zadeh Nojoo, Zhong, Kate, Fonseca, Jorge, Taghva, Kazem |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9066743/ https://www.ncbi.nlm.nih.gov/pubmed/35516416 http://dx.doi.org/10.1002/trc2.12295 |
Ejemplares similares
-
Alzheimer's disease drug development pipeline: 2021
por: Cummings, Jeffrey, et al.
Publicado: (2021) -
Alzheimer's disease drug development pipeline: 2023
por: Cummings, Jeffrey, et al.
Publicado: (2023) -
Alzheimer's disease drug development pipeline: 2018
por: Cummings, Jeffrey, et al.
Publicado: (2018) -
Alzheimer's disease drug development pipeline: 2017
por: Cummings, Jeffrey, et al.
Publicado: (2017) -
Alzheimer's disease drug development pipeline: 2019
por: Cummings, Jeffrey, et al.
Publicado: (2019)